Form 8-K - Current report:
SEC Accession No. 0001104659-24-130812
Filing Date
2024-12-20
Accepted
2024-12-20 16:10:28
Documents
17
Period of Report
2024-12-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2431511d1_8k.htm   iXBRL 8-K 30188
2 EXHIBIT 99.1 tm2431511d1_ex99-1.htm EX-99.1 13311
6 GRAPHIC tm2431511d1_ex99-1img001.jpg GRAPHIC 4420
7 GRAPHIC tm2431511d1_ex99-1img002.jpg GRAPHIC 34881
8 GRAPHIC tm2431511d1_ex99-1img003.jpg GRAPHIC 692
  Complete submission text file 0001104659-24-130812.txt   281542

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rnaz-20241218.xsd EX-101.SCH 3054
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rnaz-20241218_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rnaz-20241218_pre.xml EX-101.PRE 22385
19 EXTRACTED XBRL INSTANCE DOCUMENT tm2431511d1_8k_htm.xml XML 3795
Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Filer) CIK: 0001829635 (see all company filings)

EIN.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40363 | Film No.: 241568029
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)